Wuhan Vickor Medical Technology Co., Ltd
唯柯医疗
Wuhan Vickor Medical Technology Co., Ltd
Biotech/Healthcare
Weike Medical develops a portfolio of interventional therapies for structural heart disease. Its current products target cryptogenic stroke and heart failure.
Latest round: Series C (2024)
Source: ChinaBulls — chinabulls.com
Last updated 2024-12-01
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.